Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

US Patent 9388141 · Granted Jul 12, 2016

Estimated economic value: $246,047,000

Assignee

Inventors

View full patent text on Google Patents →